Blood transfusions in laryngeal cancer: Effect on prognosis

Head and Neck

Volumn 18, Issue 3, 1996, Pages 218-224

  León, Xavier ^a,b   Quer, Miquel ^a   Luz Maestre, M ^a   Burgués, Joaquim ^a   Muñiz, Eduardo ^a   Madoz, Pedro ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CANCER CONTROL; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; ERYTHROCYTE CONCENTRATE; FEMALE; FOLLOW UP; HUMAN; HYPOPHARYNX CARCINOMA; LARYNGECTOMY; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS;

EID: 0029913767     PISSN: 01486403     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0347(199605/06)18:3<218::aid-hed2>3.0.co;2-2     Document Type: Article

References (51)

1. Tartter PI, Heimann TM, Aufses AH Jr. Blood transfusion, skin test reactivity, and lymphocites in inflammatory bowel disease. Am J Surg 1986;151:358-361.
2. Francis DMA, Shenton BK. Blood transfusion and tumor growth: Evidence from laboratory animals. Lancet 1981;2:871.
3. Jason J, Hilgartner M, Holman RC et al. Immune status of blood product recipients. JAMA 1985;253:1140-1144.
4. Kaplan J, Sarniak S, Gitlin J, Lusher J. Diminished helper/suppressor lymphocyte ratios and natural killer activity in recipients of repeated blood transfusions. Blood 1984;64:308-310.
5. Fisher E, Lenhard V, Seifert P, Kluge A, Johannsen R. Blood-transfusion-induced suppression of cellular immunity in man. Hum Immunol 1980;3:187-194.
6. Lenhard V, Maassen G, Grose-Wilde H, Wernet P, Opek D. Effect of blood transfusions on immunoregulatory mononuclear cells in prospective transplant recipients. Transplant Proc 1983;15:1011-1015.
7. Ford CD, Warnick CT, Sheets S, Quist R, Stevens LE. Blood transfusions lower natural killer cell activity. Transplant Proc 1987;19:1456-1457.
8. Gasscon P, Zoumbros NC, Young NS. Immunologic abnormalities in patients receiving multiple blood transfusions. Ann Inter Med 1984;100:173-177.
9. Waymack JP, Gallon L, Barcelli U, Trocki O, Alexander W. Effect of blood transfusions on immune function. Alterance in macrophage arachidonic acid metabolism. Arch Surg 1987;122:56-60.
10. 2 and its role in the activation of T suppressor cells. Transplant Proc 1985;17:2380-2382.
11. Opeltz G, Terasaki PI. Dominant effect of transfusions on kidney graft survival. Transplantation 1980;29:153-158.
12. Burrows L, Tartter P. Effect of blood transfusions on colonic malignancy recurrent rate. Lancet 1982;2:662.
13. Blumberg N, Agarwald MM, Chuang C. Relationship between recurrence of cancer of the colon and blood transfusion. BR Med J [Clin Res] 1985;290:1037-1039.
14. Tartter PI, Burrows L, Papatestas AE et al. Perioperative blood transfusion has prognostic significance for breast cancer. Surgery 1985;97:225-230.
15. Herman K, Kolodziejski L. Blood transfusion and survival after surgery for stage II and III breast cancer. Neoplasm 1993;40:117-125.
16. Heal JM, Chuang C, Blumberg N. Perioperative blood transfusions and prostate cancer recurrence and survival. Am J Surg 1988;156:374-380.
17. McClinton S, Moffat LE, Scott S, Urbaniak SJ, Kerridge D F. Blood transfusion and survival following surgery for prostatic carcinoma. Br J Surg 1990;77:140-142.
18. Tartter PI, Burrows L, Kirschner P. Perioperative blood transfusion affects prognosis after resection of stage I (subset NO) non-oat-cell lung cancer. J Thorac Cardiovas Surg 1984;3:698-709.
19. Moores DW, Piantadosi S, McKneally MF. Effect of perioperative blood transfusion on outcome in patients with surgical resected lung cancer. Ann Thorac Surg 1989;47:346-351.
20. Eisenkop SM, Spirtos NM, Montag TW, Moossazadeh J, Warren P, Hendrikson M. The clinical significance of blood transfusion at the time of radical hysterectomy. Obstet Gynecol 1990;76:110-113.
21. Kaneda M, Horimi T, Ninomiya M, Nagae S, Mukai K, Takeda I et al. Adverse effect of blood transfusions on survival of patients with gastric cancer. Transfusion 1987;27:375-377.
22. Nathanson SD, Tilley BC, Schultz L et al. Perioperative allogeneic blood transfusions: Survival in patients with resected carcinomas of the colon and rectum. Arch Surg 1985;120:734-738.
23. Frankish PD, McNee RK, Alley PG et al. Relationship between cancer of the colon and blood transfusion. (Letter). Br Med J [Clin Res) 1985;290:1827.
24. Weiden PL, Bean MA, Schultz P. Perioperative blood transfusion does not increase the risk of colorectal cancer recurrence. Cancer 1987;60:870-874.
25. Foster RS Jr, Foster JC, Constanza MC. Blood transfusion and survival after surgery for breast cancer. Arch Surg 1984;119:1138-1140.
26. Eickhoff JH, Andersen PM, Norgard H. Effect of perioperative blood transfusion on recurrence and death after mastectomy for breast cancer. Acta Chir Scand 1988;154:425-428.
27. Velagapudi SE, Fiydenberg M, Oesterling JE, Bergstrlh EJ, Moore SB et al. Homologous blood transfusion in patients with prostate cancer: no effect on tumor progression or survival. Urology 1994;43:821-827.
28. Pastorino U, Valente M, Cataldo I, Lequaglie C, Ravasi G. Perioperative blood transfusion and prognosis of resected stage Ia lung cancer. Eur J Cancer Clin Oncol 1986;22:1375-1378.
29. Keller SM, Groshen S, Martini N, Kaiser LR. Blood transfusion and lung cancer recurrence. 1988;62:606-610.
30. Blumberg N, Agarwal MM, Chuang C. A possible association between survival time and transfusion in cervical cancer. Yale J Biol Med 1988;61:493-500.
31. Kampschoer GH, Maruyama K, Sasako M, Kinoshita T, van der Velde CJ. The effects of blood transfusion on the prognosis of patients with gastric cancer. World J Surg 1989;13:637-643.
32. Johnson JT, Taylor FH, Thearle PB. Blood transfusion and outcome in stage III head and neck carcinoma. Arch Otolaryngol Head Neck Surg 1987;113:307-310.
33. Jackson RM, Rice DH. Blood transfusion and recurrence in head and neck cancer. Ann Otol Rhinol Laryngol 1989;98:171-173.
34. Jones KR, Weissler MC. Blood transfusion and other risk factors for recurrence of cancer of the head and neck. Arch Otolaryngol Head Neck Surg 1990;116:304-309.
35. Bongioannini G, Vercellino M, Rugiu MG et al. Influence of perioperative transfusion therapy on the recurrence potential of locally advanced laryngeal carcinoma. ORL 1990;52:260-264.
36. Alun-Jones T, Clarke PJ, Morrissey S, Hill J. Blood transfusion and laryngeal cancer. Clin Otolaryngol 1991;16:240-244.
37. Woolley AL, Hogikyan ND, Gates GA et al. Effect of blood transfusion on recurrence of head and neck carcinoma. Retrospective review and meta-analysis. Ann Otol Rhinol Laryngol 1992;101:724-730.
38. Barra S, Barzan L, Maione A et al. Blood transfusion and other prognostic variables in the survival of patients with cancer of the head and neck. Laryngoscope 1994;104:95-98.
39. Bock M, Grevers G, Koblitz M, Heim MU, Mempel W. Influence of blood transfusion on recurrence, survival and postoperative infections of laryngeal cancer. Acta Otolaryngol (Stockh) 1990;110:155-160.
40. Ell SR, Stell PM. Blood transfusion and survival after laryngectomy for laryngeal carcinoma. J Laryngol Otol 1991;105:293-294.
41. von Doersten P, Cruz RM, Selby JV, Hilsinger RL Jr. Transfusion, recurrence, and infection in head and neck cancer surgery. Otolaryngol Head Neck Surg 1992;106:60-67
42. Schuller DE, Scott C, Wilson KM, Freer R, Al-Sarraf M et al. The effect of perioperative blood transfusion on survival in head and neck cancer. Arch Otolaryngol Head Neck Surg 1994;120:711-716.
43. International Union Against Cancer (UICC). Classification of Malignant Tumors. Berlin: Springer-verlag, 1987.
44. MacRae JD, Lampe H, Banerjee D. Blood transfusions and phenotypic immune profile in head and neck cancer patients undergoing surgical resection. J Otolaryngol 1991;20:310-314.
45. Manni JJ, Terhaard CHJ, de Boer MF et al. Prognostic factors for survival in patients with T3 laryngeal carcinoma. Am J Surg 1992;164:682-687.
46. Barona de Guzman R, Martorell MA, Basterra J, Armengot M, Alvarez-Valdés R, Garín L. Prognostic value of histopathological parameters in 51 supraglottic squamous cell carcinomas. Laryngoscope 1993;1103:538-540.
47. Hirabayashi H, Koshii K, Uno K et al. Extracapsular spread of squamous cell carcinoma in neck lymph nodes: Prognostic factor of laryngeal cancer. Laryngoscope 1991;110:502-506.
48. Bhimberg N, Heal JM, Murphy P, Agarwal MM, Chuang C. Association between transfusion of whole blood and recurrence of cancer. Br Med J 1986;293:530-533
49. Blumberg N, Heal JM, Chuang C, Murphy P, Agarwal MM. Further evidence supporting a cause and effect relationship between blood transfusion and earlier cancer recurrence. Ann Surg. 1988;207:410-415.
50. Dodd RY. The risk of transfusion-transmitted infection. N Engl J Med 1992;327:419-421.
51. McCulloch TM, Glenn MG, Riley D, Weymuller Jr EA. Blood use in head and neck tumor surgery. Potential for autologous blood. Arch Otolaryngol Head Neck Surg 1989;115:1314-1317.